Voyager Therapeutics, Inc.
VYGR
$3.17
-$0.26-7.58%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -40.93% | 15.51% | 36.54% | 36.03% | 46.19% |
Total Receivables | -38.96% | -94.68% | 504.61% | -2.96% | -86.35% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 15.79% | -29.49% | 46.71% | 20.03% | 53.45% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | 38.94% | -- | -- | -- |
Total Current Assets | -40.07% | -13.41% | 42.58% | 35.22% | 35.20% |
|
|||||
Total Current Assets | -40.07% | -13.41% | 42.58% | 35.22% | 35.20% |
Net Property, Plant & Equipment | -18.61% | 58.86% | 59.70% | 63.00% | 75.98% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -0.55% | 80.41% | 80.41% | 80.41% | 90.76% |
Total Assets | -24.78% | 11.89% | 44.59% | 38.25% | 39.64% |
|
|||||
Total Accounts Payable | -65.25% | 149.13% | -3.36% | 57.02% | 104.95% |
Total Accrued Expenses | 19.20% | -15.76% | 3.54% | 13.39% | -0.58% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 25.08% | 125.84% | 124.69% | 123.56% | 103.29% |
Total Finance Division Other Current Liabilities | -58.99% | -43.11% | -48.87% | -35.21% | 805.62% |
Total Other Current Liabilities | -58.99% | -43.11% | -48.87% | -35.21% | 805.62% |
Total Current Liabilities | -44.58% | -22.82% | -28.33% | -11.60% | 263.87% |
|
|||||
Total Current Liabilities | -44.58% | -22.82% | -28.33% | -11.60% | 263.87% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -17.69% | 113.52% | 114.12% | 114.67% | 115.13% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -59.32% | -79.01% | -66.12% | -60.92% | -82.27% |
Total Liabilities | -37.42% | -18.85% | -19.17% | -13.48% | 7.85% |
|
|||||
Common Stock & APIC | 2.64% | 25.89% | 25.91% | 26.03% | 26.17% |
Retained Earnings | -31.08% | -24.89% | 8.15% | 3.09% | -1.13% |
Treasury Stock & Other | 60.67% | -747.92% | 86.69% | -292.48% | -283.33% |
Total Common Equity | -20.00% | 26.84% | 87.44% | 68.53% | 57.12% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -20.00% | 26.84% | 87.44% | 68.53% | 57.12% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -20.00% | 26.84% | 87.44% | 68.53% | 57.12% |
|